Literature DB >> 9257918

Alterations in endothelium-dependent hyperpolarization and relaxation in mesenteric arteries from streptozotocin-induced diabetic rats.

M Fukao1, Y Hattori, M Kanno, I Sakuma, A Kitabatake.   

Abstract

1. The aim of this study was to determine whether endothelium-dependent hyperpolarization and relaxation are altered during experimental diabetes mellitus. Membrane potentials were recorded in mesenteric arteries from rats with streptozotocin-induced diabetes and age-matched controls. The resting membrane potentials were not significantly different between control and diabetic mesenteric arteries (-55.3 +/- 0.5 vs -55.6 +/- 0.4 mV). However, endothelium-dependent hyperpolarization produced by acetylcholine (ACh; 10(-8)-10(-5) M) was significantly diminished in amplitude in diabetic arteries compared with that in controls (maximum -10.4 +/- 1.1 vs -17.2 +/- 0.8mV). Furthermore, the hyperpolarizing responses of diabetic arteries were more transient. 2. ACh-induced hyperpolarization observed in control and diabetic arteries remained unaltered even after treatment with 3 x 10(-4) M N(G)-nitro-L-arginine (L-NOARG), 10(-5) M indomethacin or 60 u ml (-1) superoxide dismutase. 3. Endothelium-dependent hyperpolarization with 10(-6) M A23187, a calcium ionophore, was also decreased in diabetic arteries compared to controls (-8.3 +/- 1.4 vs -18.0 +/- 1.9 mV). However, endothelium-independent hyperpolarizing responses to 10(-6) M pinacidil, a potassium channel opener, were similar in control and diabetic arteries (-20.0 +/- 1.4 vs - 19.2 +/- 1.1 mV). 4. The altered endothelium-dependent hyperpolarizations in diabetic arteries were almost completely prevented by insulin therapy. Endothelium-dependent relaxations by ACh in the presence of l0(-4) M L-NOARG and 10(-5) M indomethacin in diabetic arteries were also reduced and more transient compared to controls. 5. These data indicate that endothelium-dependent hyperpolarization is reduced by diabetes, and this would, in part, account for the impaired endothelium-dependent relaxations in mesenteric arteries from diabetic rats.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9257918      PMCID: PMC1564820          DOI: 10.1038/sj.bjp.0701258

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

Review 1.  Endothelial dysfunction in diabetes: multiple targets for treatment.

Authors:  Hong Ding; Chris R Triggle
Journal:  Pflugers Arch       Date:  2010-03-18       Impact factor: 3.657

2.  Mesenteric arterial dysfunction in the UC Davis Type 2 Diabetes Mellitus rat model is dependent on pre-diabetic versus diabetic status and is sexually dimorphic.

Authors:  Sonali Shaligram; Farjana Akther; Md Rahatullah Razan; James L Graham; Núria Roglans; Marta Alegret; Arta Gharib Parsa; Kimber L Stanhope; Peter J Havel; Roshanak Rahimian
Journal:  Eur J Pharmacol       Date:  2020-04-19       Impact factor: 4.432

3.  Endothelium-derived hyperpolarizing factor and diabetes.

Authors:  Xue Gao; Luis A Martinez-Lemus; Cuihua Zhang
Journal:  World J Cardiol       Date:  2011-01-26

4.  Mechanisms underlying the attenuation of endothelium-dependent vasodilatation in the mesenteric arterial bed of the streptozotocin-induced diabetic rat.

Authors:  A Makino; K Ohuchi; K Kamata
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

5.  EDHF, NO and a prostanoid: hyperpolarization-dependent and -independent relaxation in guinea-pig arteries.

Authors:  M Tare; H C Parkington; H A Coleman
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

6.  NO- and non-NO-, non-prostanoid-dependent vasodilatation in rat sciatic nerve during maturation and developing experimental diabetic neuropathy.

Authors:  Kirsten Thomsen; Inger Rubin; Martin Lauritzen
Journal:  J Physiol       Date:  2002-09-15       Impact factor: 5.182

7.  The endothelium in health and disease: A discussion of the contribution of non-nitric oxide endothelium-derived vasoactive mediators to vascular homeostasis in normal vessels and in type II diabetes.

Authors:  Chris R Triggle; Hong Ding; Todd J Anderson; Malarvannan Pannirselvam
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

8.  NS309 restores EDHF-type relaxation in mesenteric small arteries from type 2 diabetic ZDF rats.

Authors:  E Brøndum; H Kold-Petersen; U Simonsen; Christian Aalkjaer
Journal:  Br J Pharmacol       Date:  2009-12-10       Impact factor: 8.739

Review 9.  Inducible endothelium-derived hyperpolarizing factor: role of the 15-lipoxygenase-EDHF pathway.

Authors:  William B Campbell; Kathryn M Gauthier
Journal:  J Cardiovasc Pharmacol       Date:  2013-03       Impact factor: 3.105

10.  Myoendothelial gap junction frequency does not account for sex differences in EDHF responses in rat MCA.

Authors:  Elke M Sokoya; Alan R Burns; Sean P Marrelli; Jie Chen
Journal:  Microvasc Res       Date:  2007-04-06       Impact factor: 3.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.